Literature DB >> 11700318

The unique solution structure and immunochemistry of the Candida albicans beta -1,2-mannopyranan cell wall antigens.

Mark Nitz1, Chang-Chun Ling, Albin Otter, Jim E Cutler, David R Bundle.   

Abstract

Synthetic oligomers of the antigenic Candida albicans (1-->2)-beta-mannopyranans adopt a compact solution conformation that leads to numerous inter-residue nuclear Overhauser effects, including unprecedented nuclear Overhauser effects between n and n + 3 residues. In excellent agreement with experimentally determined distances, unrestrained molecular dynamics point to a single family of conformations that approximate a compact helical motif with a three-residue repeat for this unique homopolymer. When the synthetic di- to hexasaccharides were employed as inhibitors of monoclonal antibodies, which protect mice against a lethal dose of the yeast pathogen, a novel pattern of inhibitor activity was observed. Instead of the paradigm first reported by Kabat (Kabat, E. A. (1962) Fed. Proc. 21, 694-701; Kabat, E. A. (1966) J. Immunol. 97, 1-11), wherein homo-oligosaccharides exhibit increasing inhibitory activity with increasing size, here the maximum activity is reached for di- and trisaccharides and diminishes significantly for tetra-, penta-, and hexasaccharides. These immunochemical data correlate with the ordered conformation of the beta-1,2-linked mannopyranan and imply that a uniquely small antigenic determinant has potential as a component of synthetic conjugate vaccines against Candida albicans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11700318     DOI: 10.1074/jbc.M109274200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Hybridoma passage in vitro may result in reduced ability of antimannan antibody to protect against disseminated candidiasis.

Authors:  Hong Xin; Jim E Cutler
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  Design of a mimotope-peptide based double epitope vaccine against disseminated candidiasis.

Authors:  Hong Xin; Pati Glee; Abby Adams; Farhan Mohiuddin; Karen Eberle
Journal:  Vaccine       Date:  2019-03-28       Impact factor: 3.641

3.  Convergent synthesis of a beta-(1-->3)-mannohexaose.

Authors:  David Crich; Baolin Wu; Prasanna Jayalath
Journal:  J Org Chem       Date:  2007-08-01       Impact factor: 4.354

Review 4.  Discovery of protective B-cell epitopes for development of antimicrobial vaccines and antibody therapeutics.

Authors:  Jacqueline Sharon; Michael J Rynkiewicz; Zhaohua Lu; Chiou-Ying Yang
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

Review 5.  Carbohydrate vaccines: developing sweet solutions to sticky situations?

Authors:  Rena D Astronomo; Dennis R Burton
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

6.  A structurally diversified linker enhances the immune response to a small carbohydrate hapten.

Authors:  Tomasz Lipinski; Thanh Luu; Pavel I Kitov; Adam Szpacenko; David R Bundle
Journal:  Glycoconj J       Date:  2011-05-05       Impact factor: 2.916

7.  Chemical structure of the cell-wall mannan of Candida albicans serotype A and its difference in yeast and hyphal forms.

Authors:  Nobuyuki Shibata; Akifumi Suzuki; Hidemitsu Kobayashi; Yoshio Okawa
Journal:  Biochem J       Date:  2007-06-15       Impact factor: 3.857

8.  Molecular recognition of Candida albicans (1->2)-β-mannan oligosaccharides by a protective monoclonal antibody reveals the immunodominance of internal saccharide residues.

Authors:  Margaret A Johnson; Jonathan Cartmell; Nina E Weisser; Robert J Woods; David R Bundle
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

Review 9.  Advances in combating fungal diseases: vaccines on the threshold.

Authors:  Jim E Cutler; George S Deepe; Bruce S Klein
Journal:  Nat Rev Microbiol       Date:  2006-12-11       Impact factor: 60.633

10.  Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis.

Authors:  Hong Xin; Sebastian Dziadek; David R Bundle; Jim E Cutler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.